[Evaluation of knocking down of the RNAi mediated gamma globin repressor into K562 cells, for gene therapy of beta-thalassemia]
Pejouhandeh: Bimonthly Research Journal. 2011; 16 (5): 234-240
em Persa
| IMEMR
| ID: emr-163624
ABSTRACT
Background and Aim:
Beta-thalassemia is a genetic disorder manifested by the presence of anemia in adult patients. One approach to treatment of beta-thalassemia is induction of the fetal gamma-globin gene. One of the gamma-globin repressors is a complex called DRED [Direct repeat erythroid-definitive]. DRED is composed of TR2 and TR4 DNA binding subunits. The aim of this study was to set up the RNAi system to increase the expression of the gamma-globin gene
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Proteínas Repressoras
/
RNA
/
Terapia Genética
/
Talassemia beta
/
Células K562
/
Gama-Globinas
Idioma:
Persa
Revista:
Pejouhandeh: Bimonthly Res. J.
Ano de publicação:
2011
Similares
MEDLINE
...
LILACS
LIS